These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Isolevuglandin adducts in disease. Salomon RG; Bi W Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218 [TBL] [Abstract][Full Text] [Related]
7. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro. Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension. Xiao L; Patrick DM; Aden LA; Kirabo A Prostaglandins Other Lipid Mediat; 2018 Nov; 139():48-53. PubMed ID: 30278231 [TBL] [Abstract][Full Text] [Related]
9. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. Roberts LJ; Salomon RG; Morrow JD; Brame CJ FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607 [TBL] [Abstract][Full Text] [Related]
10. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions. Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006 [TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry detection of isolevuglandin adduction to specific protein residues. Charvet CD; Pikuleva IA Methods Mol Biol; 2015; 1208():285-98. PubMed ID: 25323515 [TBL] [Abstract][Full Text] [Related]
12. Molecular Structures of Isolevuglandin-Protein Cross-Links. Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG Chem Res Toxicol; 2016 Oct; 29(10):1628-1640. PubMed ID: 27599534 [TBL] [Abstract][Full Text] [Related]
13. Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. Brame CJ; Salomon RG; Morrow JD; Roberts LJ J Biol Chem; 1999 May; 274(19):13139-46. PubMed ID: 10224068 [TBL] [Abstract][Full Text] [Related]
14. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts. Li W; Laird JM; Lu L; Roychowdhury S; Nagy LE; Zhou R; Crabb JW; Salomon RG Free Radic Biol Med; 2009 Dec; 47(11):1539-52. PubMed ID: 19751823 [TBL] [Abstract][Full Text] [Related]
15. Measurement of chronic oxidative and inflammatory stress by quantification of isoketal/levuglandin gamma-ketoaldehyde protein adducts using liquid chromatography tandem mass spectrometry. Davies SS; Amarnath V; Brame CJ; Boutaud O; Roberts LJ Nat Protoc; 2007; 2(9):2079-91. PubMed ID: 17853863 [TBL] [Abstract][Full Text] [Related]
17. Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples. Yermalitsky VN; Matafonova E; Tallman K; Li Z; Zackert W; Roberts LJ; Amarnath V; Davies SS Anal Biochem; 2019 Feb; 566():89-101. PubMed ID: 30458125 [TBL] [Abstract][Full Text] [Related]
18. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo. Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983 [TBL] [Abstract][Full Text] [Related]